B. Spinowitz

发表

Prediction of single-pool Kt/v based on clinical and hemodialysis variables using multilinear regression, tree-based modeling, and artificial neural networks.

A. Goldfarb-Rumyantzev, M. H. Schwenk, Samuel Liu, 2003, Artificial organs.

Fluoxetine in Depressed Patients on Dialysis

C. Charytan, B. Spinowitz, M. Blumenfield, 1997, International journal of psychiatry in medicine.

Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.

I. Macdougall, S. Fishbane, P. Pergola, 2013, The New England journal of medicine.

Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?

B. Spinowitz, Farhanah Yousaf, 2016, Current Hypertension Reports.

Hypoxia-Inducible Factor Stabilization as an Emerging Therapy for CKD-Related Anemia: Report From a Scientific Workshop Sponsored by the National Kidney Foundation.

C. Kovesdy, K. Eckardt, S. Fishbane, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Impact of epoetin beta on dialyzer clearance and heparin requirements.

C. Charytan, B. Spinowitz, J. Arslanian, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Fractional direct dialysis quantification: a new approach for prescription and monitoring hemodialysis therapy.

C. Charytan, B. Spinowitz, B. Gupta, 1996, Kidney international.

Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review

W. Winkelmayer, H. Krasa, R. Pecoits-Filho, 2019, Journal of medical economics.

Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.

V. Haase, P. Pergola, B. Spinowitz, 2016, Kidney international.

Methoxy Polyethylene Glycol-Epoetin Beta A Review of its Use in the Management of Anaemia Associated with Chronic Kidney Disease

B. Spinowitz, Wolters Kluwer, F. Locatelli, 2008 .

Ferumoxytol for treating iron deficiency anemia in CKD.

A. Kausz, B. Pereira, B. Spinowitz, 2008, Journal of the American Society of Nephrology : JASN.

Anaemia management with subcutaneous epoetin delta in patients with chronic kidney disease (predialysis, haemodialysis, peritoneal dialysis): results of an open-label, 1-year study

B. Spinowitz, U. Frei, J. Kwan, 2009, BMC nephrology.

Clinical Management of Hyperkalemia.

J. Carrero, D. Clegg, Gates B. Colbert, 2020, Mayo Clinic proceedings.

C.E.R.A. Maintains Stable Control of Hemoglobin in Patients with Chronic Kidney Disease on Dialysis when Administered Once Every Two Weeks

S. Rosansky, S. Dalal, D. Coyne, 2007, American Journal of Nephrology.

C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study

F. C. Dougherty, A. Martínez‐Castelao, M. Kessler, 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

Anemia management in patients on peritoneal dialysis: efficacy and safety of epoetin δ

B. Spinowitz, 2008, Haematologica.

The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients.

M. H. Schwenk, W. K. Bolton, M. Kaplan, 2005, Kidney international.

Early initiation of dialysis in patients with chronic progressive kidney failure does not confer a mortality advantage when compared with an approach of late initiation combined with appearance of symptoms or signs of uraemia

B. Spinowitz, 2010, Evidence Based Medicine.

Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial.

P. Lavin, E. Lerma, Bhupinder Singh, 2014, JAMA.

Course of Hyperkalemia in Patients on Hemodialysis

A. Rastogi, S. Fishbane, M. Fukagawa, 2022, International journal of nephrology.

A comparative study of continuous ambulatory peritoneal dialysis and center hemodialysis. Efficacy, complications, and outcome in the treatment of end-stage renal disease.

C. Charytan, B. Spinowitz, M. Galler, 1986, Archives of internal medicine.

CHAPTER 49 – Hydrothorax and Peritoneal Dialysis

M. H. Schwenk, C. Charytan, B. Spinowitz, 2008 .

Dialysis Adequacy in Hypoalbuminemic Continuous Ambulatory Peritoneal Dialysis Patients

C. Charytan, B. Spinowitz, B. Gupta, 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease

S. Fishbane, W. Wisemandle, B. Spinowitz, 2019, Kidney international reports.

Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.

Kimberly A. Walters, J. Wittes, W. Winkelmayer, 2021, The New England journal of medicine.

Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.

P. Raskin, K. Kalantar-Zadeh, G. Chertow, 2018, Journal of diabetes and its complications.

Novel Agents for the Prevention and Management of Hyperkalemia.

Jun Zhang, P. McCullough, M. Costanzo, 2015, Reviews in cardiovascular medicine.

Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator.

S. Wahl, C. Charytan, B. Spinowitz, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series

C. Charytan, B. Spinowitz, Farhanah Yousaf, 2015, Renal failure.

Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study

J. Butler, P. Lavin, E. Lerma, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.

Kimberly A. Walters, J. Wittes, W. Winkelmayer, 2021, The New England journal of medicine.

Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018.

S. Fishbane, B. Spinowitz, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Treatment of anemia in dif ﬁ cult-to-manage patients with chronic kidney disease

B. Spinowitz, R. Raichoudhury, 2022 .

Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data

G. Milligan, B. Spinowitz, J. Jackson, 2019, BMC Nephrology.

Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE

A. Rastogi, S. Fishbane, K. Mccafferty, 2022, BMC Nephrology.

A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.

A. Rastogi, S. Fishbane, K. Mccafferty, 2019, Journal of the American Society of Nephrology : JASN.

The existence of a protracted course in crescentic glomerulonephritis.

J. Neugarten, B. Spinowitz, H. Feiner, 1987, Kidney international.

Anemia and Oxygen Affinity in Patients on Continuous Ambulatory Peritoneal Dialysis

B. Spinowitz, M. Galler, J. Sherwood, 1983 .

Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

Mark E. Williams, P. Raskin, B. Freedman, 2004, American Journal of Nephrology.

OP-NDTJ190063 1145..1206

J. Floege, A. Rastogi, A. Covic, 2019 .

Increased Production of Fructose by the Brain in Dogs Made Diabetic by Alloxan and by Growth Hormone

N. Altszuler, B. Spinowitz, 1973, Diabetes.

Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE

E. Lerma, Bhupinder Singh, B. Spinowitz, 2019, American Journal of Nephrology.

OP-NDTJ200160 871..883

E. Lerma, S. Fishbane, S. Ash, 2021 .

Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials

E. Lerma, S. Fishbane, S. Ash, 2020, Nephrology, Dialysis and Transplantation.

Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial.

C. Charytan, B. Spinowitz, D. V. Van Wyck, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Subclavian vein stenosis as a complication of subclavian catheterization for hemodialysis.

C. Charytan, B. Spinowitz, R. Golden, 1987, Archives of internal medicine.

Comparison of eosinophilia in patients undergoing peritoneal dialysis and hemodialysis.

C. Charytan, B. Spinowitz, R. Backenroth, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients

J. Floege, A. Rastogi, A. Covic, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Therapeutic Plasmapheresis in Primary Presentation of Diabetes Mellitus With Diabetic Ketoacidosis, Hypertriglyceridemia and Acute Pancreatitis

C. Charytan, B. Spinowitz, Farhanah Yousaf, 2014 .

Safety of Iron Sucrose in Hemodialysis Patients Intolerant to Other Parenteral Iron Products

M. H. Schwenk, C. Charytan, B. Spinowitz, 2004, Nephron Clinical Practice.

Nondilated obstructive nephropathy.

C. Charytan, B. Spinowitz, R. Golden, 1983, Archives of internal medicine.

Dialysis eosinophilia.

P. Manu, C. Charytan, B. Spinowitz, 1981, Transactions - American Society for Artificial Internal Organs.

A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease.

M. Germain, B. Spinowitz, M. Kamin, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Pernicious Anemia Associated Cobalamin Deficiency and Thrombotic Microangiopathy: Case Report and Review of the Literature

C. Charytan, B. Spinowitz, Farhanah Yousaf, 2017, Case reports in medicine.

Treatment of anemia in difficult-to-manage patients with chronic kidney disease.

B. Spinowitz, R. Raichoudhury, 2021, Kidney international supplements.

Alectinib (Alecensa)-induced reversible grade IV nephrotoxicity: a case report and review of the literature

Jen-Chin Wang, B. Spinowitz, P. Ramachandran, 2018, Journal of Medical Case Reports.

Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting.

C. Kovesdy, G. Chertow, D. Charytan, 2021, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.

J. Butler, P. Lavin, E. Lerma, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Effect of Angiotensin-Converting Enzyme Inhibitors on Response to Erythropoietin Therapy in Chronic Dialysis Patients

A. Goldfarb-Rumyantzev, M. H. Schwenk, C. Charytan, 1998, American Journal of Nephrology.

Should Hemodialysis Fluid Be Sterile?

C. Charytan, B. Spinowitz, N. Meindel, 1993 .

Chapter 40 – Abdominal Hernias in Continuous Ambulatory Peritoneal Dialysis

C. Charytan, B. Spinowitz, Farhanah Yousaf, 2017 .

Reproductive Function in Dialysis Patients: CAPD vs Hemodialysis

B. Spinowitz, M. Kabadi, R. Freeman, 1983 .

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

R. Bain, B. Freedman, A. Mooradian, 1999, Controlled clinical trials.

Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.

H. Heerspink, D. Warnock, G. Chertow, 2019, Kidney international.

The Efficacy of Ferumoxytol in Peritoneal Dialysis Patients: A Short Scientific Report

C. Charytan, B. Spinowitz, Prince Mohan, 2014 .

Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review

W. Winkelmayer, H. Krasa, R. Pecoits-Filho, 2019, PharmacoEconomics - open.

The practical aspects of therapy with rHuEPO.

B. Spinowitz, 1990, American Journal of Nephrology.

Epoetin delta is effective for the management of anaemia associated with chronic kidney disease*

B. Spinowitz, R. Pratt, 2006, Current medical research and opinion.

Management of mild hyperkalemia with sodium polystyrene sulfonate: is it necessary?

C. Charytan, B. Spinowitz, Farhanah Yousaf, 2014 .

OP-NDTJ190312 137..150

J. Butler, P. Lavin, E. Lerma, 2020 .

Hypokalemia Events With Sodium Zirconium Cyclosilicate and Placebo in Hemodialysis Patients

A. Rastogi, S. Fishbane, K. Mccafferty, 2022, Kidney international reports.

Effectiveness of Sodium Zirconium Cyclosilicate in Hemodialysis Patients With Severe Hyperkalemia

A. Rastogi, S. Fishbane, K. Mccafferty, 2021, Kidney International Reports.

Dose effect analysis of sodium zirconium cyclosilicate in hemodialysis patients

A. Rastogi, K. Mccafferty, S. Bhandari, 2021, Hemodialysis international. International Symposium on Home Hemodialysis.

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

SEVERE MALNUTRITION: IV

C. Charytan, B. Spinowitz, B. Gupta, 1993 .

30: Safety and Efficacy of Ferumoxytol as an Intravenous Iron Replacement Therapy: Results from a Phase III Study of Chronic Kidney Disease (CKD) Patients not on Dialysis

B. Pereira, B. Spinowitz, M. Bernardo, 2007 .

One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis

J. Floege, A. Rastogi, A. Covic, 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Potential Angiotensin‐Converting Enzyme Inhibitor—Epoetin Alfa Interaction in Patients Receiving Chronic Hemodialysis

M. H. Schwenk, C. Charytan, B. Spinowitz, 1998, Pharmacotherapy.

Nondilated Obstructive Nephropathy

C. Charytan, B. Spinowitz, R. Golden, 1983 .

Percutaneous transluminal dilatation for vascular access.

C. Charytan, B. Spinowitz, G. Carsen, 1983, Nephron.

Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.

I. Macdougall, S. Fishbane, P. Pergola, 2013, The New England journal of medicine.

Effect of long-term epoetin beta therapy on the quality of life of hemodialysis patients.

F. Luscombe, B. Spinowitz, R. Richner, 1990, ASAIO transactions.

B. Spinowitz, 2010, Evidence Based Medicine.

Chapter 3. a. Drugs Affecting the Transport and Permeability of the Corneal Epithelium

B. Spinowitz, J. Zadunaisky, 1977 .

C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study

F. C. Dougherty, M. Kessler, K. Siamopoulos, 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

SP338ECONOMIC AND HUMANISTIC BURDEN OF DIALYSIS-DEPENDENT PATIENTS WITH CHRONIC KIDNEY DISEASE-RELATED ANEMIA: A SYSTEMATIC REVIEW

W. Winkelmayer, H. Krasa, R. Pecoits-Filho, 2018 .